KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,551,719 | $22,515,000 | 5.42% |
Prosight Management, LP | 530,062 | $7,691,000 | 4.12% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $26,118,000 | 3.20% |
Vivo Capital, LLC | 1,533,559 | $22,252,000 | 2.46% |
Frazier Life Sciences Management, L.P. | 1,572,192 | $22,813,000 | 1.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 316,133 | $4,587,000 | 1.47% |
Deep Track Capital, LP | 1,824,000 | $26,466,000 | 1.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,707,100 | $24,770,000 | 1.03% |
DAFNA Capital Management LLC | 255,313 | $3,705,000 | 1.00% |
COMMODORE CAPITAL LP | 312,553 | $4,535,000 | 0.73% |